Document is current
Any future updates will be listed below
-
Authors
Diakou, Anastasia
Morelli, Simone
Dimzas, Dimitris
Di Cesare, Angela
Capelli, Gioia
Parrinello, Chiara
Pollmeier, Matthias
Schaper, Roland
Traversa, Donato
-
Funding
Funding for this research was provided by:
Bayer HealthCare (Project 10163)
- License Information
-
More Information
Article History
Received: 10 June 2019
Accepted: 22 October 2019
First Online: 4 November 2019
Ethics approval and consent to participate
: The present study was authorized by National Organisation of Medicines of Greece (No. 25953). All study cats were privately owned naturally infected cats for which each owner signed a consent form and accepted to participate in the study. According to the Greek and European legislation, and as confirmed by the Greek Authorities for Animal Welfare (decision 311340/2166), no license related to the welfare of animals was required for the conduction of the trial.
: Not applicable.
: MP and RS are currently employed by Bayer Animal Health GmbH. AD, SM, DD, ADC, GC, CP and DT declare that they have no competing interests.
